#SPARTAN2023 @SPARTAN_Updates
Risk of flare after tapering or withdrawal of biologics/tsDMARDs in RA or AxSpA: Systematic review and metanalysis https://t.co/Bprr2qH5BP #SPARTAN2023 https://t.co/gvfOpJcZS9
Meta analysis: risk of flare with biologic discontinuation, axSpA & RA https://t.co/mHOE09Ht1q #SPARTAN2023 @SPARTAN_Updates
RT @RheumJnl: #ICYMI from our Aug issue: Risk of flare after tapering or withdrawal of b/tsDMARDs in patients with #RheumatoidArthritis or…
RT @RheumJnl: #ICYMI from our Aug issue: Risk of flare after tapering or withdrawal of b/tsDMARDs in patients with #RheumatoidArthritis or…
RT @RheumJnl: #ICYMI from our Aug issue: Risk of flare after tapering or withdrawal of b/tsDMARDs in patients with #RheumatoidArthritis or…
RT @RheumJnl: #ICYMI from our Aug issue: Risk of flare after tapering or withdrawal of b/tsDMARDs in patients with #RheumatoidArthritis or…
#ICYMI from our Aug issue: Risk of flare after tapering or withdrawal of b/tsDMARDs in patients with #RheumatoidArthritis or #AxialSpondyloarthritis: a #SystematicReview by @LineUhrenholt et al. 📖 https://t.co/uotYY7uACA https://t.co/Ff1hetd4e5
https://t.co/d3ciWg2rCu We’re proud to facilitate your access to data! #ClinicalResearch @OUPAcademic #rheumatology
RT @LineUhrenholt: Proud to present our SLR on tapering and withdrawalof b-/tsDMARDs among patients with RA and axSpA #gigt #rheumatology
RT @RheumJnl: Don't miss this SLR on tapering and withdrawal of b-/tsDAMRDs in #RheumatoidArthritis and #AxialSpondyloarthritis by @LineUhr…
RT @Janetbirdope: #ClinicalPearl. Don’t stop advanced drugs that work in #rheumatoid arthritis, #psoriatic arthritis and #ankylosing spondy…
RT @LineUhrenholt: Proud to present our SLR on tapering and withdrawalof b-/tsDMARDs among patients with RA and axSpA #gigt #rheumatology
RT @LineUhrenholt: Proud to present our SLR on tapering and withdrawalof b-/tsDMARDs among patients with RA and axSpA #gigt #rheumatology
Great paper from @LineUhrenholt! Also - Look out for the BIODOPT data on EULAR.
RT @RheumJnl: Don't miss this SLR on tapering and withdrawal of b-/tsDAMRDs in #RheumatoidArthritis and #AxialSpondyloarthritis by @LineUhr…
RT @RheumJnl: Don't miss this SLR on tapering and withdrawal of b-/tsDAMRDs in #RheumatoidArthritis and #AxialSpondyloarthritis by @LineUhr…
#ClinicalPearl. Don’t stop advanced drugs that work in #rheumatoid arthritis, #psoriatic arthritis and #ankylosing spondylitis. OK to reduce dose if in remission and escalate back up if flaring. Get rid of #glucocorticoids if you can due to AEs.
RT @RheumJnl: Don't miss this SLR on tapering and withdrawal of b-/tsDAMRDs in #RheumatoidArthritis and #AxialSpondyloarthritis by @LineUhr…
RT @RheumJnl: Don't miss this SLR on tapering and withdrawal of b-/tsDAMRDs in #RheumatoidArthritis and #AxialSpondyloarthritis by @LineUhr…
Proud to present our SLR on tapering and withdrawalof b-/tsDMARDs among patients with RA and axSpA #gigt #rheumatology
Don't miss this SLR on tapering and withdrawal of b-/tsDAMRDs in #RheumatoidArthritis and #AxialSpondyloarthritis by @LineUhrenholt et al. 👇 https://t.co/DpcCzzDcYE https://t.co/DDcCeIvZv0
RT @LineUhrenholt: Proud to share our systematic review and meta-analysis on tapering/withdrawal of b-/tsDMARDs in RA and axSpA in @RheumJn…
RT @LineUhrenholt: Proud to share our systematic review and meta-analysis on tapering/withdrawal of b-/tsDMARDs in RA and axSpA in @RheumJn…
RT @LineUhrenholt: Proud to share our systematic review and meta-analysis on tapering/withdrawal of b-/tsDMARDs in RA and axSpA in @RheumJn…
Proud to share our systematic review and meta-analysis on tapering/withdrawal of b-/tsDMARDs in RA and axSpA in @RheumJnl #arthritis #gigt #rheumaunitAAUH https://t.co/A0BoYP2XHK